difference tirzepatide and semaglutide vs. Tirzepatide: Which GLP-1 Is Right for You? Comparative safety and side effects

These medications may not be appropriate for individuals who: Are pregnant or planning pregnancy Are breastfeeding Have a history of pancreatitis Have severe gastrointestinal disorders Have certain thyroid conditions Healthcare providers will review medical history and current medications to determine suitability

An alternative hypothesis suggests that the activation of GLP-1R may influence the gut microbiome in ways that could impact both metabolic and neurological aging

Our Counseling Center offers counseling for individuals, couples, families, and groups

This dual action leads to more effective and comfortable weight loss compared to other single-hormone treatments

RESEARCH AREAS Pan-ERR (ERR//) receptor binding and agonist activation mechanisms Transcriptional regulation of mitochondrial biogenesis pathways in cell models Modulation of oxidative phosphorylation and fatty-acid oxidation gene sets PGC-1/ERR signaling-axis interactions in cultured myocyte systems WHAT RESEARCHERS LOOK AT Receptor-binding affinity and isoform selectivity assays Reporter-gene transcriptional activation readouts in transfected cell lines qPCR/RNA-seq profiling of ERR target-gene expression in vitro Compound stability, solubility, and purity verification by HPLC and mass spectrometry QUICK SPECS Form: Capsule not for ingestion Net per capsule: 100mcg Count: 60 capsules per bottle Purity: 98% (HPLC) Identity: Confirmed by mass spectrometry Storage: Cool, dry conditions away from light IDENTITY BASICS Type: Synthetic small-molecule ERR agonist (non-peptide) Molecular Formula: CHClNO Molecular Weight: ~426.9 g/mol CAS: 2756409-79-1 SELECTED RESEARCH PubChem: SLU-PP-332 compound record PubMed: ERR agonist SLU-PP-332 studies PubMed: ERR and mitochondrial biogenesis PubMed: ERR oxidative metabolism regulation DISCLAIMER For laboratory research use only

A one-time consultation fee of $50 applies